[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:treatment-resistant-depression":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":74,"states":75},"Treatment resistant depression",10,6,[8,16,22,28,34,41,47,55,62,68],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07512284","Mindfulness Engaged Neurostimulation for Depression (MEND II)",[12],"Phase 2","RECRUITING","2026-08-26T02:18:08.005333Z","2026-05-13T02:55:06.711848Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06938841","Maintenance rTMS for Depression (Maitr-De)",[],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:29.683001Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04080778","Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)",[],"2026-08-26T02:17:22.153941Z","2026-05-05T02:43:28.503666Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT04124341","PCS in Severe Treatment Resistant Depression",[],"2026-08-26T02:15:24.145250Z","2026-05-05T02:43:26.965942Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":39,"content_modified":40},"NCT06096207","DBS for Depression",[38],"Phase 1","2026-08-26T02:16:08.402952Z","2026-05-05T02:43:26.708162Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06480201","Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression",[38],"2026-08-26T02:17:39.048487Z","2026-07-19T19:36:05.135934Z",{"nct_id":48,"title":49,"phases":50,"status":52,"updated_at":53,"content_modified":54},"NCT07227103","A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial",[51],"Phase 2\u002FPhase 3","NOT_YET_RECRUITING","2026-08-26T02:15:54.846520Z","2026-07-05T05:32:16.670925Z",{"nct_id":56,"title":57,"phases":58,"status":52,"updated_at":60,"content_modified":61},"NCT07499583","Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder",[59],"Phase 1\u002FPhase 2","2026-08-26T02:15:04.877798Z","2026-05-05T02:43:29.322213Z",{"nct_id":63,"title":64,"phases":65,"status":52,"updated_at":66,"content_modified":67},"NCT07247006","Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression",[12],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:26.987075Z",{"nct_id":69,"title":70,"phases":71,"status":52,"updated_at":72,"content_modified":73},"NCT06101914","Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients",[],"2026-08-26T02:17:32.059863Z","2026-05-13T02:55:06.414730Z",[],[76,80],{"state":77,"count":78,"slug":79},"California",3,"california",{"state":81,"count":78,"slug":82},"New York","new-york"]